| The human c-abl oncogene in the Philadelphia translocation. | None |
| Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene. | None |
| Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein. | None |
| Jak-STAT signaling induced by the v-abl oncogene. | None |
| Isolation from Streptomyces of a novel naphthoquinone compound, naphthablin, that inhibits Abl oncogene functions. | None |
| Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. | None |
| In vivo antitumor activity of herbimycin A, a tyrosine kinase inhibitor, targeted against BCR/ABL oncoprotein in mice bearing BCR/ABL-transfected cells. | None |
| Oncogenic activation of c-ABL by mutation within its last exon. | None |
| Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity. | None |
| Induction of protein-tyrosine-phosphatase activity by interleukin 6 in M1 myeloblastic cells and analysis of possible counteractions by the BCR-ABL oncogene. | None |
| The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner. | None |
| The BCR-ABL oncogene requires both kinase activity and src-homology 2 domain to induce cytokine secretion. | None |
| The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3 kinase pathway. | None |
| Oncogenic potential of a pre-T cell receptor lacking the TCR beta variable domain. | None |
| p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene. | None |
| Sequences within the first exon of BCR inhibit the activated tyrosine kinases of c-Abl and the Bcr-Abl oncoprotein. | None |
| The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins. | None |
| Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL. | None |
| Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1. | None |
| Effect of Bcr sequences on the cellular function of the Bcr-Abl oncoprotein. | None |